Publications by authors named "Joshua J Short"

Claim this Profile
S
Substitution of adenovirus serotype 3 hexon onto a serotype 5 oncolytic adenovirus reduces factor X binding, decreases liver tropism, and improves antitumor efficacy.
Joshua J Short, Angel A Rivera, Hongju Wu, Mark R Walter, Masato Yamamoto

Mol Cancer Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncolytic adenoviruses targeted to cancer stem cells.
Joshua J Short, David T Curiel

Mol Cancer Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retroperitoneal and intra-abdominal sarcoma.
J Spencer Liles, Ching-Wei D Tzeng, Joshua J Short, Peter Kulesza, Martin J Heslin

Curr Probl Surg· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Members of adenovirus species B utilize CD80 and CD86 as cellular attachment receptors.
Joshua J Short, Chenthamarakshan Vasu, Mark J Holterman, David T Curiel, Alexander Pereboev

Virus Res· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adenovirus serotype 3 utilizes CD80 (B7.1) and CD86 (B7.2) as cellular attachment receptors.
Joshua J Short, Alexander V Pereboev, Yosuke Kawakami, Chenthamarakshan Vasu, Mark J Holterman

Virology· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism.
Koichi Takayama, Paul N Reynolds, Joshua J Short, Yosuke Kawakami, Yasuo Adachi

Virology· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis